Dr. Shelly David Senders, MD Inc. dba Senders Pediatrics

Cleveland, Ohio 44121

0 studies enrolling now · 3 studies all time

What they study most

Meningococcal Infection, Meningococcal Vaccine, Meningococcal Vaccines, Vaccines

Studies at this site

• Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose — Completed
• A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age — Completed
• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed